Researchers propose six areas to strengthen ClinicalTrials.gov
A critical review examines ClinicalTrials.gov, the site for clinical trials, looking past regulatory compliance needs.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
A critical review examines the ClinicalTrials.gov database and points to six areas where it could improve beyond what regulators currently require. The United States has long been a leader in biomedical discovery and new treatments.
Why it matters
The reports frame these changes as necessary to turn faster biomedical science into cures and care for patients.
Coverage
- Researchers Call for Overhaul of ClinicalTrials.gov Beyond Regulatory Compliance (BIOENGINEER.ORG)
- From Research to Care: Modernizing U.S. Clinical Studies for Cures into Care (healthpolicy.duke.edu)
More from Health
- Lancet study urges climate change be declared global health emergency
- NIH launches new vaccine injury center under HHS initiative
- Georgia health officials confirm three new measles cases
- Arizona providers warn Medicaid cuts will crowd emergency rooms
- Artiva halts autoimmune cell therapy and cuts 94% of staff
- FDA outlines faster approval route for custom gene therapies